![Arthur Y. Elliott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arthur Y. Elliott
Corporate Officer/Principal chez
American Association for the Advancement of Science
Profil
Arthur Y.
Elliott is a professional with current memberships in the American Association for the Advancement of Science, The Society for in Vitro Biology, and the American Society for Microbiology.
He previously worked as the Executive Director-Biological Operations at Merck & Co., Inc. and as the Chief Scientific Officer at PharmAthene, Inc. He also served as an Independent Director at iBio, Inc. from 2010 to 2019 and as a Manager-Senior Program at the US Department of Health & Human Services (DC) from 2010 to 2013.
Dr. Elliott holds a doctorate degree from Purdue University and undergraduate and graduate degrees from the University of North Texas.
Currently, he is a member of the American Association for the Advancement of Science, The Society for in Vitro Biology, and the American Society for Microbiology.
Postes actifs de Arthur Y. Elliott
| Sociétés | Poste | Début |
|---|---|---|
American Association for the Advancement of Science
 American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services Provides science related journal, program, and education services | Corporate Officer/Principal | 12/11/2010 |
American Society for Microbiology
 American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services Provides professional education services | Corporate Officer/Principal | 12/11/2010 |
The Society for in Vitro Biology
 The Society for in Vitro Biology Miscellaneous Commercial ServicesCommercial Services Provides biological research services | Corporate Officer/Principal | 12/11/2010 |
Anciens postes connus de Arthur Y. Elliott
| Sociétés | Poste | Fin |
|---|---|---|
| IBIO, INC. | Directeur/Membre du Conseil | 01/04/2019 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Directeur Technique/Scientifique/R&D | - |
US Department of Health & Human Services
 US Department of Health & Human Services General GovernmentGovernment Governmental department | Corporate Officer/Principal | - |
Formation de Arthur Y. Elliott
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Texas
 University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Department of Health & Human Services
US Department of Health & Human Services General GovernmentGovernment Governmental department | Government |
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services Provides science related journal, program, and education services | Commercial Services |
The Society for in Vitro Biology
The Society for in Vitro Biology Miscellaneous Commercial ServicesCommercial Services Provides biological research services | Commercial Services |
American Society for Microbiology
American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services Provides professional education services | Commercial Services |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
